Inovio Pharmaceuticals IncInovio Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The analysis of Inovio Pharmaceuticals Inc is assembled by All Street Sevva using proprietary Cognitive Robots. The Disclosure score covers seventeen United Nations Sustainable Development Goals including: 'Good Health & Wellbeing', 'Sustainable Cities & Communities' and 'Life below Water'. Full Sustainability assessment of Inovio Pharmaceuticals Inc are accessed by logging in.

Inovio Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 4.8, social score of 4.8 and governance score of 4.0.

SDG Transparency Score for Inovio Pharmaceuticals Inc 
Low
0 - 3

4.9

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Inovio Pharmaceuticals Inc 
4.8

Environmental

4.8

Social

4.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
1047SQZ Biotechnologies Co
5.0
High
1047Zenabis Global Inc
5.0
High
1082Inovio Pharmaceuticals Inc
4.9
High
1082AngioLab Inc
4.9
High
1082Annexon Inc
4.9
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Inovio Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc offer flexible work?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose water use targets?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Inovio Pharmaceuticals Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Inovio Pharmaceuticals Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Inovio Pharmaceuticals Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose its waste policy?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose energy use targets?

LockedSign up for free to unlock

Does Inovio Pharmaceuticals Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Inovio Pharmaceuticals Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Inovio Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

Sorry!

Failed to process!